IBRN:NYE-iShares Trust - iShares Neuroscience and Healthcare ETF (USD)

ETF | Others |

Last Closing

USD 25.4753

Change

0.00 (0.00)%

Market Cap

USD 3.84M

Volume

194.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index. It is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-22 )

ETFs Containing IBRN

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.87% 9% A- 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.87% 7% C- 18% F
Trailing 12 Months  
Capital Gain 21.17% 64% D 64% D
Dividend Return 0.03% 1% F 1% F
Total Return 21.20% 59% D- 57% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -1.88% 27% F 28% F
Dividend Return -1.87% 19% F 16% F
Total Return 0.00% 2% F 1% F
Risk Return Profile  
Volatility (Standard Deviation) 7.11% 64% D 85% B
Risk Adjusted Return -26.37% 19% F 12% F
Market Capitalization 3.84M 8% B- 3% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.